This approach combines a sulfur cathode and a novel electrolyte to improve specific capacity and cycle stability in lithium-sulfur batteries, indicating significant advances in battery technology.
Lithium-sulfur (Li-S) batteries are identified as one of the most promising next-generation battery technologies. However, commercialization of Li-S batteries has not been widespread due to severe technical challenges, such as lithium polysulfide dissolution and shuttling inherent to the battery chemistry. In this work, we demonstrate a strategy of integrating a nanoengineered sulfur cathode with a functionalized electrolyte to overcome some of the major technical barriers and realize the high specific capacity and high-performance potentials of Li-S batteries. The nanoengineered sulfur cathode, architectured by applying an ultrathin film of nanolayer-polymer-coated-carbons on a sulfur electrode, is able to achieve a high discharge specific capacity of ∼1600 mAh/g, approaching sulfur's theoretical specific capacity of 1672 mAh/g, due to the increased redox kinetics and the PS-trapping power. The functionalized electrolyte is designed by utilizing, for the first time, 2,2,3,3-tetrafluoro-1,4-dimethoxybutane (FDMB) as a cosolvent in the Li-S electrolyte, which helps maintain the high specific capacity over extended cycles due to the strong PS-trapping power enabled by FDMB. This strategy rendered not only the highest possible specific discharge capacity but also an unprecedented cycle stability (90% capacity retention after 500 cycles at 1 C rate) in the resultant Li-S batteries. The unprecedented level of performance, along with the near-theoretical high specific capacity, was realized without using complex processes and costly materials. The synergistic strategy used in this work represents a significant advancement of the Li-S battery technology, with unprecedented high specific capacity, which can render high energy density, robust cycle life, and enhanced safety, toward commercialization.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: